Key players in the global subcutaneous immunoglobulin market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global subcutaneous immunoglobulin market. A few expansion strategies adopted by players operating in the global subcutaneous immunoglobulin market are:
The report on the global subcutaneous immunoglobulin market discussed individual strategies, followed by company profiles of manufacturers of subcutaneous immunoglobulin. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global subcutaneous immunoglobulin market.
Global Subcutaneous Immunoglobulins Market - Segmentation
Application |
Primary Immunodeficiency Diseases Secondary Immunodeficiency Diseases Others |
End-user |
Hospital Clinic Home Care Setting |
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Subcutaneous immunoglobulin market to reach US$ 12.2 Bn by 2027
Subcutaneous immunoglobulin market is anticipated to expand at a CAGR of 13.1% from 2019 to 2027
Subcutaneous immunoglobulin market is driven by rise in prevalence of autoimmune disorders and increase in global geriatric population
North America accounted for major share of the global subcutaneous immunoglobulin market
Key players in the global subcutaneous immunoglobulin market include Biotest AG, CSL Limited, Grifols, S.A. Kedrion S.p.A., Octapharma AG, Takeda Pharmaceutical Company Limited
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Subcutaneous immunoglobulins Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Subcutaneous immunoglobulins Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Development in the Market
5.2. Key Success Factors for Top 3 Market Players
5.3. Mergers & Acquisitions
6. Global Subcutaneous immunoglobulins Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Subcutaneous immunoglobulins Market Value Forecast, by Application, 2017–2027
6.2.1. Primary Immunodeficiency Diseases
6.2.2. Secondary Immunodeficiency Diseases
6.2.3. Others
6.3. Global Subcutaneous immunoglobulins Market Attractiveness, by Application
7. Global Subcutaneous immunoglobulins Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Subcutaneous immunoglobulins Market Value Forecast, by End-user, 2017–2027
7.2.1. Hospital
7.2.2. Clinic
7.2.3. Others
7.3. Global Subcutaneous immunoglobulins Market Attractiveness, by End-user
8. Global Subcutaneous immunoglobulins Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Subcutaneous immunoglobulins Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. North America Subcutaneous immunoglobulins Market Attractiveness, by Region
9. North America Subcutaneous immunoglobulins Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027
9.2.1. Primary Immunodeficiency Diseases
9.2.2. Secondary Immunodeficiency Diseases
9.2.3. Others
9.3. North America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027
9.3.1. Hospital
9.3.2. Clinic
9.3.3. Others
9.4. North America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Subcutaneous immunoglobulins Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Subcutaneous immunoglobulins Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.2.1. Primary Immunodeficiency Diseases
10.2.2. Secondary Immunodeficiency Diseases
10.2.3. Others
10.3. Europe Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027
10.3.1. Hospital
10.3.2. Clinic
10.3.3. Others
10.4. Europe Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Subcutaneous immunoglobulins Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Subcutaneous immunoglobulins Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.2.1. Primary Immunodeficiency Diseases
11.2.2. Secondary Immunodeficiency Diseases
11.2.3. Others
11.3. Asia Pacific Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027
11.3.1. Hospital
11.3.2. Clinic
11.3.3. Others
11.4. Asia Pacific Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Subcutaneous immunoglobulins Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Subcutaneous immunoglobulins Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.2.1. Primary Immunodeficiency Diseases
12.2.2. Secondary Immunodeficiency Diseases
12.2.3. Others
12.3. Latin America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027
12.3.1. Hospital
12.3.2. Clinic
12.3.3. Others
12.4. Latin America Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America Latin America
12.5. Latin America Subcutaneous immunoglobulins Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Subcutaneous immunoglobulins Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.2.1. Primary Immunodeficiency Diseases
13.2.2. Secondary Immunodeficiency Diseases
13.2.3. Others
13.3. Middle East & Africa Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by End-user, 2017–2027
13.3.1. Hospital
13.3.2. Clinic
13.3.3. Others
13.4. Middle East & Africa Subcutaneous immunoglobulins Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Subcutaneous immunoglobulins Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by Tier and Size of companies)
14.2. Market Share / Position Analysis, by Company, 2019
14.3. Company Profiles
14.3.1. Biotest AG
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Analysis
14.3.1.3. Growth Strategies
14.3.1.4. SWOT Analysis
14.3.2. CSL Limited (CSL Behring)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Analysis
14.3.2.3. Growth Strategies
14.3.2.4. SWOT Analysis
14.3.3. Grifols, S.A.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Analysis
14.3.3.3. Growth Strategies
14.3.3.4. SWOT Analysis
14.3.4. Kedrion S.p.A.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Analysis
14.3.4.3. Growth Strategies
14.3.4.4. SWOT Analysis
14.3.5. Octapharma AG
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Analysis
14.3.5.3. Growth Strategies
14.3.5.4. SWOT Analysis
14.3.6. Takeda Pharmaceutical Company Limited
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Analysis
14.3.6.3. Growth Strategies
14.3.6.4. SWOT Analysis
14.3.7. Bio Products Laboratory Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Analysis
14.3.7.3. Growth Strategies
14.3.7.4. SWOT Analysis
14.3.8. LFB S.A.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Analysis
14.3.8.3. Growth Strategies
14.3.8.4. SWOT Analysis
14.3.9. Other prominent Players
List of Table
Table 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 02: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 03: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 04: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017-2027
Table 05: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country, 2017–2027
Table 07: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2017–2027
Table 08: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 09: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 10: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017-2027
Table 11: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017–2027
Table 12: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 13: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Application, 2017-2027
Table 14: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by End-user, 2017-2027
Table 15: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 16: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Application, 2017-2027
Table 17: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by End-user, 2017-2027
Table 18: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
List of Figure
Figure 01: Global Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2019–2027
Figure 02: Market Value Share, by Application (2018)
Figure 03: Market Value Share, by End-user (2018)
Figure 04: Market Value Share, by Region (2018)
Figure 05: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2018 and 2027
Figure 06: Global Subcutaneous Immunoglobulin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Primary Immunodeficiency Diseases, 2017–2027
Figure 07: Global Subcutaneous Immunoglobulin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secondary Immunodeficiency Diseases, 2017–2027
Figure 08: Global Subcutaneous Immunoglobulin Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 09: Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application, 2019-2027
Figure 10: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2018 and 2027
Figure 11: Global SCIG Market Revenue (US$ Mn), by Hospitals, 2017–2027
Figure 12: Global SCIG Market Revenue (US$ Mn), by Clinics, 2017–2027
Figure 13: Global SCIG Market Revenue (US$ Mn), by Home Care, 2017–2027
Figure 14: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user, 2019-2027
Figure 15: Global Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Region, 2018 and 2027
Figure 16: Global Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Region
Figure 17: North America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2017–2027
Figure 18: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country, 2019-2027
Figure 19: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2018 and 2027
Figure 20: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2018 and 2027
Figure 21: North America Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country, 2018 and 2027
Figure 22: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application, 2017–2025
Figure 23: North America Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user, 2017–2025
Figure 24: Europe Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 25: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 26: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2018 and 2027
Figure 27: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2018 and 2027
Figure 28: Europe Subcutaneous Immunoglobulin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 29: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application, 2019-2027
Figure 30: Europe Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user, 2019-2027
Figure 31: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast, 2017–2027
Figure 32: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 33: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Application, 2018 and 2027
Figure 34: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by End-user, 2018 and 2027
Figure 35: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 36: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by Application, 2017–2025
Figure 37: Asia Pacific Subcutaneous Immunoglobulin (SCIG) Market Attractiveness Analysis, by End-user, 2017–2025
Figure 38: Latin America Subcutaneous Immunoglobulin (SCIG) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 39: Latin America SCIG Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 40: Latin America SCIG Market Value Share Analysis, by Application, 2018 and 2027
Figure 41: Latin America SCIG Market Value Share Analysis, by End-user, 2018 and 2027
Figure 42: Latin America SCIG Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 43: Latin America SCIG Market Attractiveness Analysis, by Application, 2019-2027
Figure 44: Latin America SCIG Market Attractiveness Analysis, by End-user, 2019-2027
Figure 45: Middle East & Africa Subcutaneous Immunoglobulin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
Figure 46: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 47: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Application, 2018 and 2027
Figure 48: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by End-user, 2018 and 2027
Figure 49: Middle East & Africa Subcutaneous Immunoglobulin Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 50: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by Application, 2019–2027
Figure 51: Middle East & Africa Subcutaneous Immunoglobulin Market Attractiveness Analysis, by End-user, 2019–2027
Figure 52: Global Subcutaneous Immunoglobulin (SCIG) Market Share Analysis, by Company (2019)